BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving research platform. New compounds and evidence are added continuously.
B

Nelumbo Nucifera

A plant genus of the family NELUMBONACEAE. The common name lotus is also used for other plants such as the WATER-LILY, which they resemble, and the unrelated genus Lotus (LOTUS). Nelumbo produce the edible lotus nuts.

200+ PubMed studies analyzed · 1 RCTs · Evidence Score: 31.1

Research Domains

Nelumbo Nucifera has been studied across 22 research domains including 🔬 Inflammation, 🔥 Metabolic, 🧘 Stress & Anxiety, 🔬 Oncology, 🫁 Liver & Detox. The primary research focus is 🔬 Inflammation with 16% of studies addressing this area.

Traditional Use (Ayurveda)

Known as lian / 蓮藕 in Ayurveda. Karma (actions): Stops thirst, Expels the placenta and breaks Blood, Generates original Qi, Assists the Spleen and Stomach, Astricts seminal discharge and slippery [loss], Disperses stasis Blood, Disperses water swelling and welling-abscess swelling, Promotes eruption of pox sores, Kills mushroom toxins.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Nelumbo Nucifera, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Panax
7961 shared targets
eriobotrya
7068 shared targets
scutellaria
7205 shared targets
aloe
7964 shared targets
ephedra
7583 shared targets
ziziphus
7497 shared targets
eucommia
6965 shared targets
prunus
7111 shared targets
Syzygium
6956 shared targets
arctium
7550 shared targets
Loading evidence profile...

This evidence profile for Nelumbo Nucifera is generated deterministically from 200 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.